Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;2(2):128-31.
doi: 10.4103/2231-4040.82951.

Formulation and evaluation of aceclofenac mouth-dissolving tablet

Shailendra Singh Solanki  1 , Rashmi Dahima
Affiliations

Formulation and evaluation of aceclofenac mouth-dissolving tablet

Shailendra Singh Solanki et al. J Adv Pharm Technol Res. 2011 Apr.

Abstract

Aceclofenac has been shown to have potent analgesic and anti-inflammatory activities similar to indomethacin and diclofenac, and due to its preferential Cox-2 blockade, it has a better safety than conventional Non steroidal anti-inflammatory drug (NSAIDs) with respect to adverse effect on gastrointestinal and cardiovascular systems. Aceclofenac is superior from other NSAIDs as it has selectivity for Cox-2, a beneficial Cox inhibitor is well tolerated, has better Gastrointestinal (GI) tolerability and improved cardiovascular safety when compared with other selective Cox-2 inhibitor. To provide the patient with the most convenient mode of administration, there is need to develop a fast-disintegrating dosage form, particularly one that disintegrates and dissolves/disperses in saliva and can be administered without water, anywhere, any time. Such tablets are also called as "melt in mouth tablet." Direct compression, freeze drying, sublimation, spray drying, tablet molding, disintegrant addition, and use of sugar-based excipients are technologies available for mouth-dissolving tablet. Mouth-dissolving tablets of aceclofenac were prepared with two different techniques, wet granulation and direct compression, in which different formulations were prepared with varying concentration of excipients. These tablets were evaluated for their friability, hardness, wetting time, and disintegration time; the drug release profile was studied in buffer Phosphate buffered Saline (PBS) pH 7.4. Direct compression batch C3 gave far better dissolution than the wet granulation Batch F2, which released only 75.37% drug, and C3, which released 89.69% drug in 90 minutes.

Keywords: Aceclofenac; dry granulation; geriatric; mouth-dissolving tablet; pediatric; wet granulation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Graphical representation of comparative dissolution profile of batch F1, F2, F3, and C3. F1: Wet granulation; F2: Wet granulation; F3: Wet granulation; C3: Direct compression
See this image and copyright information in PMC

References

    1. Abdelbary G, Prinderre P, Couani C, Taochim J, Reynier JP, Riccerelle P, et al. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004;278:423–33. - PubMed
    1. Reddy LH, Ghosh B, Rajneesh, et al. Fast dissolving drug delivery system; a review of the literature. Indian J Pharm sci. 2002;64:331–6.
    1. Bi Y, Sunanda H, Yonezawa Y, Danjo K, Otsuka A, Iida K, et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996;44:2121–7. - PubMed
    1. Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull. 1995;18:1308–10. - PubMed
    1. Machalson J. Rapidly disintegrating tablet composition and method. [Last accessed on 1983]. Available from: http://www.freepatentsonline.com/4414198.htm. US patent 4414198 .